Annual Report 2012

Profile
Striving to be the Best in the Global Market
Since the Nipro Corporation was founded in 1954, we have focused on developing our business based on our
technological prowess. Our first breakthrough was the development of an automated processing machine for glass
ampoules. This machine enjoyed an excellent reputation for its efficient production techniques and standardized
product quality.
With expertise accumulated from processing various materials, the Group moved into the medical business
in 1965 through selling infusion sets to pharmaceutical companies. Our mass production technology enabled us
to expand the scope of our business and we hit our stride in 1988 when we started to manufacture the Dialyzer
artificial kidney, which is still one of our leading products to this day. That same year we expanded our business into
pharmaceuticals. Our injectable kit preparations, which combine the drug with the administration system, plays on
our strengths as derived from our experience in manufacturing medical equipment. Since the 1990’s we have also
advanced into overseas markets as well as working to establish global sales hubs. Today the Nipro Group continues
to grow as one of Japan’s leading medical manufacturers, with branches in about 90 locations throughout Europe,
Asia and North and South America.
The corporate philosophy of the Nipro Group is “conducting business from various aspects, contributing to
society and promoting self-realization with creativity and innovation for the future.” While engaged in active and
speedy business development, our mission is to contribute to progress towards more reassuring, safer medical care,
in addition to improving the patient’s QOL (quality of life) through continuous improvement of our products from the
perspective of both patients and healthcare professionals. We will provide innovative products that meet customer
needs in addition to striving to excel in the manufacture of medical devices as well as pharmaceuticals, etc.
Contents
1 Profile
2 Consolidated Financial Highlights
3 A Message to Our Shareholders and Investors
7 At a Glance
9 Global Activities
13 Research and Development
15 Plant and Equipment
19 Status of Corporate Governance, etc.
21 Corporate Social Responsibility
22 Board of Directors and Auditors
Disclaimer regarding Forward-looking Statements
This report contains forward-looking statements regarding business indices, strategies and performance representing the expectations and judgments of the
management, based on information available to the Company and publishable at the time this report was prepared.
When reading this report, please understand that forward-looking statements involve potential risks and uncertainties; actual future business performance and
forecasts may therefore differ materially from those contained in these statements, given the possible emergence of new factors or changes in economic circumstances
and/or the business environment.
1 Nipro Corporation Annual Report 2012
23 Financial Review
27 10 Year Summary
29 Consolidated Balance Sheets
31 Consolidated Statements of Income
32 Consolidated Statements of Changes in Net Assets
33 Consolidated Statements of Cash Flows
34 Notes to Consolidated Financial Statements
47 Report of Independent Auditors
48 Corporate Information